Anti‐cytokine vaccines and the immunotherapy of autoimmune diseases
Open Access
- 30 October 2006
- journal article
- editorial
- Published by Wiley in European Journal of Immunology
- Vol. 36 (11) , 2844-2848
- https://doi.org/10.1002/eji.200636760
Abstract
Three papers in this issue of the European Journal of Immunology describe the use of cytokine vaccines to prevent autoimmune disease in experimental animals. The vaccines are based on interleukin 17 (IL‐17), a cytokine that has recently been shown to play a central role in inflammation.See accompanying articles: http://dx.doi.org/10.1002/eji.200636484; http://dx.doi.org/10.1002/eji.200636658; http://dx.doi.org/10.1002/eji.200636662Keywords
This publication has 33 references indexed in Scilit:
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapyCurrent Opinion in Infectious Diseases, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationThe Journal of Experimental Medicine, 2005
- Requirement of Interleukin‐17A for Systemic Anti–Candida albicansHost Defense in MiceThe Journal of Infectious Diseases, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- T Helper Cell Subsets in Insulin-Dependent DiabetesScience, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Two types of mouse helper T-cell clone: Implications for immune regulationImmunology Today, 1987